{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T18:34:15Z","timestamp":1789929255729,"version":"4.0.1"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,3]],"date-time":"2015-06-03T00:00:00Z","timestamp":1433289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0128368","type":"journal-article","created":{"date-parts":[[2015,6,3]],"date-time":"2015-06-03T17:59:00Z","timestamp":1433354340000},"page":"e0128368","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients"],"prefix":"10.1371","volume":"10","author":[{"given":"Giuseppina Rosaria Rita","family":"Ricciardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Licata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Cardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppa","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tindara","family":"Franchina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tuccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Adamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,6,3]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molonc.2010.11.003","article-title":"Deconstructing the molecular portraits of breast cancer","volume":"5","author":"A Prat","year":"2011","journal-title":"Mol Oncol"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ejca.2011.06.028","article-title":"Management and treatment of triple-negative breast cancer patients from the NEMESI study: an Italian experience","volume":"48","author":"V Adamo","year":"2012","journal-title":"Eur J Cancer"},{"issue":"20","key":"ref3","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"WD Foulkes","year":"2010","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"ref4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1634\/theoncologist.2011-S1-71","article-title":"Directed therapy of subtypes of triple-negative breast cancer","volume":"16","author":"LA Carey","year":"2011","journal-title":"Oncologist"},{"issue":"18","key":"ref5","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1016\/j.ejca.2008.09.034","article-title":"What is triple-negative breast cancer?","volume":"44","author":"WJ Irvin Jr","year":"2008","journal-title":"Eur J Cancer"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/bcr2852","article-title":"Stratifying triple-negative breast cancer: which definition(s) to use?","volume":"13","author":"B Adamo","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10549-011-1619-7","article-title":"Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse","volume":"132","author":"JC Harrell","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/cncr.23930","article-title":"Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases","volume":"113","author":"NU Lin","year":"2008","journal-title":"Cancer"},{"issue":"Suppl 1","key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1634\/theoncologist.2011-S1-01","article-title":"Triple-negative breast cancer: an unmet medical need","volume":"16","author":"CA Hudis","year":"2011","journal-title":"Oncologist"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"R68","DOI":"10.1186\/bcr2635","article-title":"Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer","volume":"12","author":"A Prat","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1158\/1078-0432.CCR-07-1943","article-title":"Are triple-negative and basal-like breast cancer synonymous?","volume":"14","author":"E Rakha","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"16","key":"ref12","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","article-title":"Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma","volume":"10","author":"TO Nielsen","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"5","key":"ref13","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","article-title":"Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype","volume":"14","author":"MC Cheang","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ijc.23518","article-title":"How basal are triple-negative breast cancers?","volume":"123","author":"F Bertucci","year":"2008","journal-title":"Int J Cancer"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/00313020802563510","article-title":"Triple-negative\/basal-like breast cancer: review","volume":"41","author":"EA Rakha","year":"2009","journal-title":"Pathology"},{"issue":"19","key":"ref16","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"T S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1524-4741.2011.01175.x","article-title":"The paradox of triple negative breast cancer: novel approaches to treatment","volume":"18","author":"M Fornier","year":"2012","journal-title":"Breast J"},{"issue":"Suppl 1","key":"ref18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1634\/theoncologist.2011-S1-61","article-title":"Molecular stratification of triple-negative breast cancers","volume":"16","author":"CM Perou","year":"2011","journal-title":"Oncologist"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"BD Lehmann","year":"2011","journal-title":"J Clin Invest"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13058-014-0406-x","article-title":"PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors","volume":"16","author":"BD Lehmann","year":"2014","journal-title":"Breast Cancer Res"},{"key":"ref21","unstructured":"Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua S, et al. Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-negative Breast Cancer. Clin Cancer Res. 2014 Sep 10. pii: clincanres.0432.2014. [Epub ahead of print]"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0960-0760(01)00185-6","article-title":"Roles of androgens in the development, growth, and carcinogenesis of the mammary gland","volume":"80","author":"DJ Liao","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00428-005-0003-6","article-title":"Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma","volume":"447","author":"C Riva","year":"2005","journal-title":"Virchows Arch"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/1097-0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO;2-H","article-title":"Androgen receptors in breast cancer","volume":"54","author":"RM Bryan","year":"1984","journal-title":"Cancer"},{"issue":"5995","key":"ref25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/bmj.4.5995.503","article-title":"Oestrogen and androgen receptors in breast cancer and response to endocrine therapy","volume":"4","author":"JP Persijn","year":"1975","journal-title":"Br Med J"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PPO.0b013e3181ce4ae1","article-title":"Triple-negative breast cancer: role of the androgen receptor","volume":"16","author":"A Gucalp","year":"2010","journal-title":"Cancer J"},{"issue":"2","key":"ref27","first-page":"111","article-title":"The role of androgens in mammary carcinogenesis","volume":"106","author":"YC Wong","year":"2001","journal-title":"Ital J Anat Embryol"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1023\/A:1018730519839","article-title":"Role of the androgen receptor in human breast cancer","volume":"3","author":"SN Birrell","year":"1998","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"7","key":"ref29","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1158\/1078-0432.CCR-08-1763","article-title":"Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer","volume":"15","author":"AM Gonzalez-Angulo","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1365-2559.2010.03724.x","article-title":"Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations","volume":"57","author":"G Pristauz","year":"2010","journal-title":"Histopathology"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12032-011-9832-0","article-title":"Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray","volume":"29","author":"J He","year":"2012","journal-title":"Med Oncol"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/BST0360149","article-title":"Regulation of cell-cell adhesion by the cadherin-catenin complex","volume":"36","author":"WJ Nelson","year":"2008","journal-title":"Biochem Soc Trans"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrm1699","article-title":"Regulation of cadherin-mediated adhesion in morphogenesis","volume":"6","author":"BM Gumbiner","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1476-4598-9-179","article-title":"Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition","volume":"9","author":"YL Chao","year":"2010","journal-title":"Mol Cancer"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/sj.bjc.6605735","article-title":"Significance of E-cadherin expression in triple-negative breast cancer","volume":"103","author":"S Kashiwagi","year":"2010","journal-title":"Br J Cancer"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12032-011-9948-2","article-title":"The expression and clinical significance of the androgen receptor and E-cadherin in triple-negative breast cancer","volume":"29","author":"D Tang","year":"2012","journal-title":"Med Oncol"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/bcr3068","article-title":"Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67","volume":"13","author":"S Kashiwagi","year":"2011","journal-title":"Breast Cancer Res"},{"issue":"4","key":"ref38","first-page":"867","article-title":"Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67","volume":"138","author":"J Gerdes","year":"1991","journal-title":"Am J Pathol"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(09)70262-1","article-title":"Ki67 in breast cancer: prognostic and predictive potential","volume":"11","author":"R Yerushalmi","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/jclinpath-2012-201085","article-title":"Ki67 and proliferation in breast cancer","volume":"66","author":"N Pathmanathan","year":"2013","journal-title":"J Clin Pathol"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/annonc\/mdp510","article-title":"Expression of androgen receptors in primary breast cancer","volume":"21","author":"S Park","year":"2010","journal-title":"Ann Oncol"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"A Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"issue":"12","key":"ref43","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrclinonc.2010.154","article-title":"Triple-negative breast cancer: disease entity or title of convenience?","volume":"7","author":"L Carey","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 2","key":"ref44","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","article-title":"Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer","volume":"9","author":"CK Anders","year":"2009","journal-title":"Clin Breast Cancer"},{"issue":"10","key":"ref45","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1158\/1078-0432.CCR-12-2986","article-title":"Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer","volume":"19","author":"KD Yu","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref46","article-title":"Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis","volume":"106","author":"FE Vera-Badillo","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"ref47","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1158\/1078-0432.CCR-12-3327","article-title":"Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer","volume":"19","author":"A Gucalp","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.22381","article-title":"Prognostic markers in triple-negative breast cancer","volume":"109","author":"EA Rakha","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-008-0081-7","article-title":"The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer","volume":"116","author":"RL Jones","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"ref50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0959-8049(03)00675-0","article-title":"Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy","volume":"40","author":"T Petit","year":"2004","journal-title":"Eur J Cancer"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2407-7-203","article-title":"Prognostic impact of clinicopathologic parameters in stage II\/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer","volume":"7","author":"B Keam","year":"2007","journal-title":"BMC Cancer"},{"issue":"22","key":"ref52","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djr393","article-title":"Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group","volume":"103","author":"M Dowsett","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"ref53","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2559.2005.02156.x","article-title":"E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance","volume":"46","author":"EA Rakha","year":"2005","journal-title":"Histopathology"},{"issue":"2","key":"ref54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10549-006-9248-2","article-title":"E-cadherin immunohistochemical expression as a prognostic factor in infiltrating ductal carcinoma of the breast: a systematic review and meta-analysis","volume":"100","author":"Rothberg BE Gould","year":"2006","journal-title":"Breast Cancer Res Treat"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0132647","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T00:00:00Z","timestamp":1435795200000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0128368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T01:03:56Z","timestamp":1540256636000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0128368"}},"subtitle":[],"editor":[{"given":"Daniele","family":"Santini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,3]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0128368","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0132647","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,3]]}}}